文献速递产科妇科

剖宫产瘢痕妊娠:治疗选择的系统综述

Cesarean Scar Pregnancies: A Systematic Review of Treatment Options.
PubMed 文献 · J Minim Invasive Gynecol · 2017-07-18

本系统综述评估剖宫产瘢痕妊娠(CSP)治疗方案的疗效与安全性,检索MEDLINE、Embase和Cochrane Library至2016年6月,纳入63项报告至少10例CSP治疗结局的英文研究。全身甲氨蝶呤和/或局部注射甲氨蝶呤或氯化钾的总体成功率为62%;期待治疗活产率57%,但63%因胎盘植入异常或孕中期子宫破裂需行子宫切除术。

要点

  • 全身甲氨蝶呤和/或局部注射甲氨蝶呤或氯化钾的总体成功率为62%。
  • 期待治疗活产率57%,但63%因胎盘植入异常或孕中期子宫破裂需行子宫切除术。
  • 腹腔镜、阴式及开腹切除并修补缺陷成功率≥96%、出血风险≤4%。

核心结论

  • 让CSP继续进展会使孕妇面临危及生命的大出血和子宫切除术的高风险。
  • 单纯药物治疗往往不足。
  • 在筛选合适的患者中或联合子宫动脉栓塞时,刮宫术是合理的选择。
  • 切除并修补瘢痕缺陷对后续妊娠结局的潜在益处需进一步评估。

研究设计与样本

  • 系统综述,检索MEDLINE、Embase和Cochrane Library自建库至2016年6月及参考文献列表。
  • 纳入报告至少10例CSP治疗结局的英文出版物,共纳入63项研究。
  • 由两名作者筛选合格性、提取数据并评估纳入研究的质量。
  • 治疗成功定义为索引治疗后无需后续干预。

主要发现

  • 全身甲氨蝶呤和/或局部注射甲氨蝶呤或氯化钾的总体成功率为62%。
  • 刮宫术与28%的出血风险相关,联合子宫动脉栓塞后出血风险降至4%。
  • 宫腔镜切除CSP在12%的病例中不成功,人绒毛膜促性腺激素下降不足是额外干预的主要指征。
  • 腹腔镜、阴式及开腹切除并修补缺陷的成功率高(≥96%),出血风险低(≤4%)。
  • 期待治疗活产率为57%,但63%的妇女因胎盘植入异常或孕中期子宫破裂需行子宫切除术。

临床怎么用

  • 作者认为,让CSP继续进展会使孕妇面临危及生命的大出血和子宫切除术的高风险。
  • 作者认为,单纯药物治疗往往不足。
  • 作者认为,在筛选合适的患者中或联合子宫动脉栓塞时,刮宫术是合理的选择。
  • 作者提出,切除并修补瘢痕缺陷对后续妊娠结局的潜在益处需进一步评估。

局限性

  • 大多数研究方法学质量低。
  • 鉴于研究间和研究组间的异质性,认为对治疗方案进行统计学比较不恰当。
  • 切除并修补瘢痕缺陷对后续妊娠结局的潜在益处需进一步评估。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

The objective of this systematic review was to assess the efficacy and safety of treatment options of cesarean scar pregnancies (CSPs). We searched MEDLINE, Embase, and the Cochrane Library from inception to June 2016 as well as reference lists. We included English publications reporting treatment outcomes of at least 10 cases of CSPs. Two authors screened for eligibility, extracted data, and assessed the quality of the included studies. Treatment was considered successful if no subsequent intervention was required after the index treatment. Of the 1257 citations identified, 63 studies were eligible. The overall success rate of systemic methotrexate (MTX) and/or local injection of MTX or potassium chloride was 62%. Dilation and curettage (D&C) was associated with a 28% risk of hemorrhage that dropped to 4% when combined with uterine artery embolization (UAE). Hysteroscopic resection of CSP was unsuccessful in 12% of cases, and inadequate human chorionic gonadotropin decay was the primary indication for additional intervention. Laparoscopic, vaginal, and open excision and repair of the defect were associated with a high success rate (≥96%) and a low risk of hemorrhage (≤4%). Expectant management resulted in a 57% live birth rate, but 63% of women required hysterectomy because of placental implantation abnormalities or second trimester uterine rupture. Most studies were of low methodologic quality, and given the heterogeneity between the studies and groups, statistical comparison of treatment options was deemed inappropriate. In conclusion, the decision to allow the progression of CSPs exposes women to a high risk of life-threatening hemorrhage and hysterectomy. Medical treatment options alone are often insufficient. D&C is a reasonable option in well-selected women or when combined with UAE. The potential benefits of excision and repair of scar defect on further pregnancy outcomes need to be further assessed.

来源:J Minim Invasive Gynecol,查看原文。版权归原作者所有。

引用

  1. Maheux-Lacroix S, Li F, Bujold E, et al. Cesarean Scar Pregnancies: A Systematic Review of Treatment Options. J Minim Invasive Gynecol. 2017. PMID: 28599886. doi:10.1016/j.jmig.2017.05.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。